Work

[IC‐P‐041]: SAMPLE SIZES FOR 24‐MONTH ALZHEIMER's PREVENTION TRIALS USING BIOMARKER ENDPOINTS IN COGNITIVELY UNIMPAIRED AMYLOID‐POSITIVE ADULTS

Year: 2017

Type: article

Source: Alzheimer s & Dementia

DOI: 10.1016/j.jalz.2017.06.2313

Authors: Eric M. Reiman, Xiaoying Kuang, Ji Luo, Yinghua Chen, Pradeep Thiyyagura, Robert Bauer, Wendy Lee, Hillary Protas, Dhruman D. Goradia, Paul S. Aisen, Keith Johnson, Jessica B. Langbaum, Reisa A. Sperling, Pierre Tariot, William J. Jagust, Michael Weiner, Kewei Chen

Institutions: Translational Genomics Research Institute, University of Arizona, Banner Alzheimer’s Institute, Arizona Alzheimer’s Consortium, Arizona State University, University of Southern California, Harvard University, Massachusetts General Hospital, Brigham and Women's Hospital, Athinoula A. Martinos Center for Biomedical Imaging, Lawrence Berkeley National Laboratory, University of California, San Francisco, University of California, Berkeley, San Francisco VA Medical Center

Language: English

Topic: Dementia and Cognitive Impairment Research

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2765392508

FWCI:

Cites:

Cited by:

Related to: 10